Skip to main content

Table 1 Budget impact analysis model parameters

From: Budget impact analysis of the use of Souvenaid in patients with prodromal Alzheimer’s Disease in Spain

  

Source

Model characteristics

 Number of patients

89,030

 

 Number of replications

1

 

 Cutoff for mild AD

4.5

[31]

 Cutoff for moderate AD

9.5

[31]

Population characteristics

 Population projections by age group (2020–2035)

INE

 

 Incidence rates

Literature

[26]

 Age of the caregiver (mean)

55.2

[15]

 Baseline CDR-SB score (mean)

1.76

[15]

 Baseline MMSE score (mean)

26.9

[15]

Annual costs (mean)

[32] payer

 Treatment with Souvenaid (per year)

€1200

Patient

 Diagnosis

€284

Health service

 Direct healthcare for mild AD

€3388

Health service

 Direct social care for mild AD

€13,927

F&SS

 Indirect for mild AD

€647

 

 Total for mild AD

€17,962

 

 Direct healthcare for moderate/severe AD

€4659

Health service

 Direct social care for moderate/severe AD

€34,893

F&SS

 Indirect for moderate/severe AD

€820

 

 Total for moderate/severe AD

€40,372

 
  1. AD Alzheimer’s disease, CDR-SB Clinical Dementia Rating-Sum of Boxes, MMSE Mini-Mental State Exam, F&SS Family &Social Services